The second day of what at times appeared to provide catharsis for prospective jurors against pharmaceutical executive Martin Shkreli ended on Tuesday without a jury in the securities fraud case.

More than 130 potential jurors were dismissed on Monday, many saying they could not serve because of work commitments and medical reasons. But some were bounced after saying they could not be impartial in a trial for the so-called Pharma bro and seemed to use the proceedings to vent their feelings about the pharmaceutical industry, big business generally or Shkreli specifically.

The second day of jury selection began with Benjamin Brafman, Shkreli's lead counsel, calling for a mistrial in the case, citing unfair media coverage of the first day of jury selection, but Eastern District Judge Kiyo Matsumoto denied the motion.